Plus therapeutics to participate in upcoming virtual conferences

Austin, texas, march 03, 2021 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing novel, targeted therapies for rare and difficult to treat cancers, today announced that marc hedrick, m.d., president and chief executive officer of plus therapeutics, will present at the following upcoming virtual conferences.
pstv Ratings Summary
pstv Quant Ranking